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Introduction
Tasks on free ranging pinnipeds such as blood and tissue sampling, or 
attachment of instruments often require remote immobilization. This is 
essential for elephant seal bulls, whose body mass mostly exceeds 1.5 tons. 
Basically, they are accessable when they stay ashore during breeding and 
moulting. Invasive studies, however, can be performed only during the 
moulting period as immobilization of breeding bulls impairs heavily the 
colonies‘ social structure. During moulting, they fast and hence undergo 
considerable metabolic changes. The individuals‘ constitutions are then 
highly variable, and the reaction to external stimuli is unpredictable. At this 
time, males aggregate tightly in large groups (Fig. 1), and estimation of body 
mass is difficult. Field conditions in polar regions additionally aggravate 
immobilization as remote injection devices are mainly designed for temperate 
areas. To enable our recent studies on wild elephant seal bulls, the method 
of distance immobilization was applied in due consideration of the species 
and the environment.
Discussion
LA Immobilon® appears to be useful as a short-term or first-step immobilization agent in elephant seal bulls by remote 
injection owing to its small volume required. Etorphine-Immobilizations without subsequent use of other drugs (e.g. 
ketamine) may be sufficient for short-term handlings such as blood sampling. The combined effect of Immobilon® and 
ketamine appears suitable for long-term or invasive tasks such as tissue sampling or attachment of intruments (Fig. 
6). We nevertheless suggest that LA Immobilon® should only be used as a kind of pre-medication, not used 
repeatedly in the same individual, and solely if the specific antidote (LA Revivon®) is ready. It has further to be 
realized that LA Immobilon® is potentially dangerous for personnel, especially when used in remote areas.
Fig. 3 CO2 powered rifle with dart 
syringes
Fig. 4 Drugs used: LA 
Immobilon® (etorphine HCl) 
and LA Revivon ®
(diprenorphine HCl)
Fig. 2   Research area: King George Island,
South Shetland Islands, Antarctica
Research site
Fig. 1 Adult males moulting ashore
Material and Methods
Twenty-seven males were immobilized after their moulting period (March to May 2000, King George Island) for various tasks. 
The body mass and disposition was roughly assessed. Then the immobilization was performed by two steps. Firstly, a 10 ml 
self-evacuating dart syringe (Telinject®, Fig. 3) was filled with 0.25-0.8 ml Large Animal Immobilon® (2.4 mg etorphine/ 10 mg 
acepromacine/ ml LA Immobilon® , Fig. 4), and complemented by 9 ml of sterile NaCl solution (0.9%). Canules (2 x 80mm) 
were locked to the syringe by custom made aluminium safety connectors (Ludolph, Bremerhaven). The projectiles were 
darted using a CO2 -powered rifle (G.U.T. 50, Telinject®) over a distance of ca. 5 to 20 m (2 to 4 bar) placed intramuscularly 
into the lateral hip area. Secondly, as touch of the animal was possible and breathing and reflexes appeared regularly, 
immobilization was maintained by manually injected subsequent doses of ketamine (100mg/ml) according to lid reflex, colour 
of mucosal tissues, breathing rate, and degree of muscle relaxation. The etorphine-antidote Large Animal Revivon® (3mg/ml 
diprenorphine HCl) was ready for i.v./i.m. injection in case of apnea and/or convulsions (Table 1). During narcosis, the body
mass was recalculated using the regression equation for male elephant seals based on standard body length (Ling & Bryden 
1981).
Precautions: For safety reasons on personnel, the antidote Narcanti® (0,4mg/ml Naloxon) was ready during any handling of 
LA Immobilon®. Trained staff should be aboard.
Table 1 Data of immobilization
duration
follow-up doses [n] total dose [mg/kg] [min]
1 1168 0,00210 0,00876 3 6 0,0077* convulsions
2 1148 0,00051 0,00214 5 5 6,8 55
3 1245 0,00067 0,00281 8 2 3,2 75
4 1365 0,00062 0,00257 11 2 2,9 135
5 1380 0,00061 0,00254 17 3 3,3 75 disturbed
6 1460 0,00058 0,00242 10 3 2,7 155 0,0180** died
7 1250 0,00096 0,00400 no effect/to sea
8 1255 0,00096 0,00399 14 1 1,6 170
9 1550 0,00062 0,00258 12 1 1,0 low effect
10 1380 0,00070 0,00290 30 3 2,4 105
11 1400 0,00069 0,00288 no effect/to sea
12 1230 0,00078 0,00325 13 1 0,8 65
13 1900 0,00063 0,00263 4 1,9 low effect
14 1850 0,00104 0,00433 15 1 0,3 95
15 1900 0,00101 0,00421 7 2 0,6 65 0,0032
16 2150 0,00089 0,00372 10 1 0,9 90
17 1900 0,00076 0,00316 15 110 0,0066
18 2025 0,00095 0,00395 7 1 0,6 55
19 1675 0,00086 0,00358 10 3 1,3 50 0,0064
20 1415 0,00102 0,00424 15 1 0,8 60 0,0065
21 1615 0,00089 0,00372 16 2 0,6 50
22 1565 0,00092 0,00384 25 1 1,0 50 0,0028*
23 1845 0,00104 0,00434 28 1 0,8 40
24 1965 0,00098 0,00407 15 2 0,9 90 0,0023*
25 1675 0,00086 0,00359 4 2,6 low effect
26 1515 0,00095 0,00396 30 5 2,6 105
27 1880 0,00102 0,00426 15 2 0,7 70 0,0036
mean 1581,7 0,00087 0,00365 14,4 2,2 1,7 80,5 0,0052
SD 288,2 0,00029 0,00121 7,3 1,3 1,4 37,7 0,0015
remarksseal diprenorphine [mg/kg]
ketamine













































Fig. 5 Correlation (neg, p<0.01) between dosages 
of etorphine given and ketamine required for 
suitable immobilization
Results
The data of immobilization are displayed 
in table 1. The total dosages of ketamine 
required (x=1.7 mg/kg) were negatively 
correlated (p<0.01, Fig. 5) with those of 
LA Immobilon® (0.0009 mg/kg etorphine). 
The dosages of LA Immobilon® were 
markably lower than recommended for 
other large-sized mammal species (Born 
& Knutsen 1990, Griffith et al. 1993) and 
the therapeutic range was low. In 9 cases 
the application of the etorphine-antidote 
LA RevIvon® (x=0.0052 mg/kg diprenor-
phine) was required to antagonize apnea 
and/or convulsions. 
Fig. 6 Male with attached instrument 
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